ASP Isotopes (NASDAQ:ASPI) COO Robert Ainscow Sells 25,000 Shares of Stock

ASP Isotopes Inc. (NASDAQ:ASPI) COO Robert Ainscow sold 25,000 shares of the stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $3.90, for a total value of $97,500.00. Following the transaction, the chief operating officer owned 2,256,879 shares in the company, valued at $8,801,828.10. This trade represents a 1.10% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Robert Ainscow also recently made the following trade(s):

• On Monday, June 8th, Robert Ainscow sold 8,438 shares of ASP Isotopes stock. The stock was sold at an average price of $7.00, for a total transaction of $59,066.00.

ASP Isotopes Trading Up 7.7%

Shares of ASP Isotopes stock opened at $4.20 on Friday. The company has a current ratio of 3.87, a quick ratio of 3.85 and a debt-to-equity ratio of 0.76. ASP Isotopes Inc. has a twelve month low of $3.51 and a twelve month high of $14.49. The firm has a market capitalization of $643.90 million, a PE ratio of -3.18 and a beta of 3.59. The firm’s 50-day moving average price is $4.37 and its 200 day moving average price is $5.20.

ASP Isotopes (NASDAQ:ASPI) last announced its earnings results on Friday, August 14th. The company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.11). The firm had revenue of $5.12 million for the quarter, compared to analyst estimates of $4.47 million. ASP Isotopes had a negative net margin of 427.98% and a negative return on equity of 64.99%.

Institutional Investors Weigh In On ASP Isotopes

Several large investors have recently added to or reduced their stakes in ASPI. Amundi purchased a new stake in shares of ASP Isotopes during the second quarter worth $107,000. California State Teachers Retirement System grew its holdings in ASP Isotopes by 864.2% during the 2nd quarter. California State Teachers Retirement System now owns 754,131 shares of the company’s stock worth $4,691,000 after acquiring an additional 675,919 shares in the last quarter. AXQ Capital LP purchased a new stake in shares of ASP Isotopes in the 2nd quarter valued at approximately $80,000. Headlands Technologies LLC increased its position in shares of ASP Isotopes by 219.6% in the 2nd quarter. Headlands Technologies LLC now owns 240,197 shares of the company’s stock valued at $1,494,000 after purchasing an additional 165,031 shares during the last quarter. Finally, Alyeska Investment Group L.P. raised its holdings in shares of ASP Isotopes by 5.6% in the 2nd quarter. Alyeska Investment Group L.P. now owns 2,843,503 shares of the company’s stock valued at $17,687,000 after purchasing an additional 151,337 shares in the last quarter. 16.80% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ASPI has been the subject of several analyst reports. Wall Street Zen upgraded ASP Isotopes from a “strong sell” rating to a “sell” rating in a report on Saturday, August 22nd. Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a report on Wednesday, June 24th. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, ASP Isotopes currently has an average rating of “Hold” and an average target price of $13.00.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.